InvestorsHub Logo
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Re: Gottahavemballs post# 25544

Friday, 07/20/2018 10:12:10 PM

Friday, July 20, 2018 10:12:10 PM

Post# of 233765
Especially when they have a monoclonal antibody that can go after HIV, cancer, Multiple Scleroris, GvHD, other autoimmune diseases. What big pharma wouldn't want a safe version of a monoclonal antibody that could target all these diseases?

CEO even mentioned that Pfizer is working on a CCR5 drug in cancer of its own I believe, but I think he stated they have more toxicity on their version. I will have to go back and listen. But that's what I thought I heard.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News